2m 2m 2m 2m 2m 2m 2m
Harrow (HROW)
NASDAQ
$41.25+$0.30 (+0.74%)
Price as of Aug 21, 2026 7:55 PM EDT- $1.5BMarket Cap
- 4.68%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Harrow (HROW)
$41.25+$0.30 (+0.74%)
Earnings Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 6 |
Momentum Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 36.51% | ||
12-Month Momentum | 9.75% | ||
3-Month Risk Adjusted Momentum | 167.54% | ||
12-Month Risk Adjusted Momentum | 15.40% |
True Yield
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.02% |
Financial Health Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |